drug · protein

AT-278

Phase 1updated 3mo ago

by Arecor Therapeutics Plc🔗 ChEMBL

Phase 1

community read0 votes

🐶 often sniffed alongside

top 5

Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 46 investigational indications.

targets

Insulin receptor

all catalysts(0)

nothing on the calendar yet

Trials studying AT-278

phase4Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetescompletedn=33

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 8m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · protein

save

AT-278

Phase 1updated 3mo ago

by Arecor Therapeutics Plc🔗 ChEMBL

Phase 1

community read0 votes

🐶 often sniffed alongside

top 5

Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 46 investigational indications.

targets

Insulin receptor

all catalysts(0)

nothing on the calendar yet

Trials studying AT-278

phase4Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetescompletedn=33

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 8m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

AT-278

🐶 often sniffed alongside

targets

all catalysts(0)

Trials studying AT-278

News(0)

Report a data issue

comments(0)

AT-278

🐶 often sniffed alongside

targets

all catalysts(0)

Trials studying AT-278

News(0)

Report a data issue

comments(0)